Ajanta Pharma Limited (NSE:AJANTPHARM)

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 20, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	305,675	327,581	280,899	154,878	154,667	155,056
Market Cap Growth	-26.96%	16.62%	81.37%	0.14%	-0.25%	30.05%
Enterprise Value	300,046	320,489	276,473	149,016	149,244	150,485
Last Close Price	2447.60	2623.00	2210.78	1166.93	1158.85	1141.80
PE Ratio	32.89	35.59	34.42	26.34	21.70	23.71
Forward PE	28.54	31.53	31.03	20.52	19.55	23.58
PS Ratio	6.36	7.05	6.67	4.14	4.63	5.37
PB Ratio	8.06	8.64	7.87	4.57	4.74	5.18
P/TBV Ratio	8.16	8.75	7.91	4.58	4.75	5.20
P/FCF Ratio	-	39.03	44.40	25.08	37.46	38.31
P/OCF Ratio	-	28.31	35.78	19.55	27.54	26.91
PEG Ratio	-	1.58	1.55	2.89	1.49	1.06
EV/Sales Ratio	6.24	6.90	6.57	3.98	4.47	5.21
EV/EBITDA Ratio	23.00	25.59	23.76	18.74	16.27	15.22
EV/EBIT Ratio	25.70	28.40	26.44	21.92	18.47	16.90
EV/FCF Ratio	-	38.19	43.70	24.13	36.15	37.18
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.04	0.04	0.03	0.05	0.04	0.04
Debt / FCF Ratio	-	0.06	0.06	0.06	0.08	0.09
Asset Turnover	-	0.96	0.90	0.86	0.85	0.81
Inventory Turnover	-	1.32	1.36	1.38	1.14	1.08
Quick Ratio	-	1.85	1.98	1.71	2.15	1.85
Current Ratio	-	2.85	3.05	2.49	3.50	3.13
Return on Equity (ROE)	-	25.02%	23.47%	17.68%	22.77%	23.38%
Return on Assets (ROA)	-	14.61%	14.03%	9.73%	12.89%	15.68%
Return on Capital (ROIC)	19.60%	18.95%	18.59%	12.63%	15.95%	19.49%
Return on Capital Employed (ROCE)	-	28.10%	27.90%	19.20%	23.70%	28.40%
Earnings Yield	3.04%	2.81%	2.91%	3.80%	4.61%	4.22%
FCF Yield	-	2.56%	2.25%	3.99%	2.67%	2.61%
Dividend Yield	1.14%	1.07%	1.63%	0.60%	0.55%	0.56%
Payout Ratio	-	37.96%	78.68%	15.25%	11.54%	12.68%
Buyback Yield / Dilution	0.82%	0.66%	1.65%	1.19%	0.74%	0.21%
Total Shareholder Return	1.97%	1.73%	3.28%	1.79%	1.28%	0.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.